As of 2026-09-19, the EV/EBITDA ratio of WAVE Life Sciences Ltd (WVE) is -2.19. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. WVE's latest enterprise value is 468.93 mil USD. WVE's TTM EBITDA according to its financial statements is -214.32 mil USD. Dividing these 2 quantities gives us the above WVE EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 2.2x - 6.4x | 4.3x |
| Forward P/E multiples | 1.5x - 7.3x | 4.4x |
| Fair Price | (0.54) - (5.22) | (2.93) |
| Upside | -112.4% - -219.9% | -167.4% |
| Date | EV/EBITDA |
| 2026-09-18 | -2.19 |
| 2026-09-17 | -2.27 |
| 2026-09-16 | -2.33 |
| 2026-09-15 | -2.29 |
| 2026-09-14 | -2.39 |
| 2026-09-11 | -2.40 |
| 2026-09-10 | -2.48 |
| 2026-09-09 | -2.60 |
| 2026-09-08 | -2.69 |
| 2026-09-04 | -2.65 |
| 2026-09-03 | -2.50 |
| 2026-09-02 | -2.66 |
| 2026-09-01 | -2.74 |
| 2026-08-31 | -2.68 |
| 2026-08-28 | -2.81 |
| 2026-08-27 | -2.92 |
| 2026-08-26 | -2.98 |
| 2026-08-25 | -3.00 |
| 2026-08-24 | -2.88 |
| 2026-08-21 | -3.03 |
| 2026-08-20 | -3.00 |
| 2026-08-19 | -3.14 |
| 2026-08-18 | -3.03 |
| 2026-08-17 | -2.85 |
| 2026-08-14 | -3.14 |
| 2026-08-13 | -2.95 |
| 2026-08-12 | -2.99 |
| 2026-08-11 | -2.81 |
| 2026-08-10 | -3.73 |
| 2026-08-07 | -3.76 |
| 2026-08-06 | -3.69 |
| 2026-08-05 | -3.61 |
| 2026-08-04 | -3.67 |
| 2026-08-03 | -3.44 |
| 2026-07-31 | -3.23 |
| 2026-07-30 | -3.45 |
| 2026-07-29 | -3.50 |
| 2026-07-28 | -3.57 |
| 2026-07-27 | -3.60 |
| 2026-07-24 | -3.50 |
| 2026-07-23 | -3.47 |
| 2026-07-22 | -3.44 |
| 2026-07-21 | -3.48 |
| 2026-07-20 | -3.43 |
| 2026-07-17 | -3.51 |
| 2026-07-16 | -3.37 |
| 2026-07-15 | -3.59 |
| 2026-07-14 | -3.79 |
| 2026-07-13 | -3.62 |
| 2026-07-10 | -3.89 |